Evidence for the neuronal origin of immunoreactive interleukin-1 beta released by rat hypothalamic explants

Neurosci Lett. 1996 Nov 29;219(3):143-6. doi: 10.1016/s0304-3940(96)13195-5.

Abstract

In this study, we have investigated the release of immunoreactive interleukin-1 beta (irIL-1 beta) from the rat hypothalamus in vitro. It was found that (1) tissue explants release sizable amounts of irIL-1 beta (ranging from 0.43 to 0.52 pg/mg of wet tissue) in 20 min incubations; (2) basal release in significantly increased by depolarization induced with 56 mM KCl; (3) K(+)-induced irIL-1 beta release is inhibited by the specific blocker of N-type calcium channels, omega-conotoxin, and by verapamil, but not by nifedipine; (4) K(+)-induced release is also inhibited by the Na+ channel blockers tetrodotoxin and lidocaine; (5) irIL-1 beta release is significantly increased by noradrenalin; such increase is antagonized by verapamil and the beta-blocker propranolol, but not by the alpha-blocker phentolamine. The present evidence suggests that irIL-1 beta released by rat hypothalamic explants following KCl depolarization is neuronal in origin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium Channel Blockers / pharmacology
  • Electrophysiology
  • Hypothalamus / drug effects
  • Hypothalamus / metabolism*
  • Hypothalamus / physiology
  • In Vitro Techniques
  • Interleukin-1 / antagonists & inhibitors
  • Interleukin-1 / metabolism*
  • Male
  • Neurons / metabolism*
  • Norepinephrine / pharmacology
  • Potassium Chloride / pharmacology
  • Radioimmunoassay
  • Rats
  • Rats, Wistar
  • Sodium Channel Blockers

Substances

  • Calcium Channel Blockers
  • Interleukin-1
  • Sodium Channel Blockers
  • Potassium Chloride
  • Norepinephrine